Transgene Biotek Ltd. | Income Statement
Fiscal year is April-March. All values INR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
150,138.50
9,686.40
3,231.10
1,769.80
2,794.00
Cost of Goods Sold (COGS) incl. D&A
159,631.60
187,869.70
184,280.30
213,277.60
182,110.50
Gross Income
9,493.10
178,183.30
181,049.20
211,507.80
179,316.50
SG&A Expense
8,848.10
11,831.10
6,300.90
4,298.00
21,525.60
EBIT
18,341.30
190,425.50
187,697.00
216,335.90
200,842.10
Unusual Expense
600.00
1,151,694.10
60.20
-
4,358.10
Non Operating Income/Expense
521.90
8,000.00
-
1,683.00
424.00
Interest Expense
1,924.60
4.90
3,597.40
731.00
723.30
Pretax Income
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
Consolidated Net Income
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
Net Income
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
Net Income After Extraordinaries
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
Net Income Available to Common
20,344.00
1,334,124.50
191,354.70
215,383.90
196,783.20
EPS (Basic)
0.31
17.61
2.53
2.84
2.60
Basic Shares Outstanding
65,770.00
75,770.00
75,770.00
75,770.00
75,770.00
EPS (Diluted)
0.31
18.98
2.53
2.84
2.60
Diluted Shares Outstanding
65,770.00
70,290.50
75,770.00
75,770.00
75,770.00
EBITDA
8,190.50
18,270.20
15,891.90
11,312.40
25,570.70
Other Operating Expense
-
411.10
346.90
530.10
-
About Transgene Biotek
View Profile
